SCHEMBL158757

SCHEMBL158757

OCCCCc1[c]cccc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.33
LTA4H P09960 1/20 0.33
EPHX2 P34913 1/20 0.33
CA2 P00918 2/20 0.32
KDM4E B2RXH2 4/20 0.31
KCNH3 Q9ULD8 1/20 0.31
ALDH1A1 P00352 3/20 0.30
RECQL P46063 1/20 0.30
CYP4F2 P78329 2/20 0.30
CYP4A11 Q02928 2/20 0.30
TBXAS1 P24557 1/20 0.30
MAPT P10636 2/20 0.30
GAA P10253 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3584431 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3593788 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3587337 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3590954 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3585941 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3582720 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3594353 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3599432 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3589051 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E
SCHEMBL3594988 0.98 CA2 (0.33) TDP1LTA4HEPHX2CA2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611804-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT Forma TM, LLC. (US) 2013-07-10 EP claimed
WO-2012031197-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT FORMA THERAPEUTICS, INC. (US) 2012-03-08 WO claimed
US-7998542-B2 Composition, retardation plate, liquid-crystal display device, and method for producing retardation plate FUJIFILM CORPORATION (JP) 2011-08-16 US disclosed
US-7989037-B2 A layer of discotic liquid-crystal and an anisotropic fluoropolymer of acrylic esters, e.g., 4-((4-nitrilophenoxy)butyl acrylate /2-(perfluorhexyl)ethyl acrylate copolymer; providing stability/optical compensation; no defects from optical fluctuation or alignment failure; controlling the tilt angle FUJIFILM CORPORATION (JP) 2011-08-02 US disclosed
US-7741242-B2 Prepared by crosslinking a homogenized an addition polymer containing units from an unsaturated aryl-containing glycidyl ether or ester and an unsaturated alcohol or carboxylic acid and a zero-valent Pd compound to physically deposit the Pd compound on the polymer; oxidizing alcohols to aldehydes WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2010-06-22 US disclosed
US-20090174844-A1 Composition, Retardation Plate, Liquid-Crystal Display Device, and Method for Producing Retardation Plate FUJIFILM CORPORATION (JP) 2009-07-09 US disclosed
EP-1537913-B1 PALLADIUM CATALYST COMPOSITION WAKO PURE CHEMICAL INDUSTIES L (JP) 2009-07-01 EP disclosed
US-20080090027-A1 Composition, retardation plate, and liquid-crystal display device FUJIFILM CORPORATION (JP) 2008-04-17 US disclosed
WO-2007083848-A1 COMPOSITION, RETARDATION PLATE, LIQUID-CRYSTAL DISPLAY DEVICE, AND METHOD FOR PRODUCING RETARDATION PLATE FUJIFILM CORPORATION (JP) 2007-07-26 WO disclosed
US-20060178486-A1 Propylene block copolymer MITSUBISHI CHEMICAL CORPORATION (JP) 2006-08-10 US disclosed
EP-1645576-A1 PROPYLENE BLOCK COPOLYMER Mitsubishi Chemical Corporation (JP) 2006-04-12 EP disclosed
EP-1592685-A1 BIPHENYL DERIVATIVES HAVING &bgr; sb 2 /sb ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY Theravance Inc (US) 2005-11-09 EP disclosed
EP-1537913-A1 PALLADIUM CATALYST COMPOSITION Wako Pure Chemical Industies, Ltd. (JP) 2005-06-08 EP disclosed
WO-2004074276-A1 BIPHENYL DERIVATIVES HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY THERAVANCE INC. (US) 2004-09-02 WO disclosed
US-4948809-A TREATMENT OF AILMENTS DUE TO THROMBOCYTE AGGREGATION OR KIDNEY DYSFUNCTION BOEHRINGER MANNHEIM GMBH (DE) 1990-08-14 US disclosed
US-4906662-A Phenol derivatives, their preparation and the use thereof OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1990-03-06 US disclosed
EP-0263229-A1 Phenol derivatives, their preparation and the use thereof OTSUKA PHARMACEUTICAL FACTORY, INC. (JP) 1988-04-13 EP disclosed
US-RE30240-E Arthropodicidal and nematocidal phosphoramidates ROHM AND HAAS COMPANY (US) 1980-03-25 US disclosed
US-4139614-A FOR HUMAN AND VETERINARY MEDICINE ROHM AND HAAS COMPANY (US) 1979-02-13 US disclosed
US-4087521-A Arthropodicidal and nematocidal phosphoramidates ROHM AND HAAS COMPANY (US) 1978-05-02 US disclosed